2019
Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia
WERNER, Y. B., B. HAKANSON, J. MARTINEK, A. REPICI, Rahden BHA. VON et. al.Základní údaje
Originální název
Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia
Autoři
WERNER, Y. B., B. HAKANSON, J. MARTINEK, A. REPICI, Rahden BHA. VON, A. J. BREDENOORD, R. BISSCHOPS, H. MESSMANN, M. C. VOLLBERG, T. NODER, J. F. KERSTEN, O. MANN, J. IZBICKI, A. PAZDRO, U. FUMAGALLI, R. ROSATI, C. T. GERMER, M. P. SCHIJVEN, A. EMMERMANN, Renteln D. VON, P. FOCKENS, G. BOECKXSTAENS a T. ROSCH
Vydání
New England Journal of Medicine, Waltham, Massachussetts Medical Society, 2019, 0028-4793
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30230 Other clinical medicine subjects
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 74.699
UT WoS
000505219800007
Klíčová slova česky
PNEUMATIC DILATIONADVERSE EVENTSHELLER MYOTOMYPOEMOUTCOMESRISK
Klíčová slova anglicky
PNEUMATIC DILATIONADVERSE EVENTSHELLER MYOTOMYPOEMOUTCOMESRISK
Příznaky
Mezinárodní význam
Změněno: 7. 12. 2021 13:47, Bc. Hana Vladíková, BBA
Anotace
V originále
BACKGROUND Pneumatic dilation and laparoscopic Heller's myotomy (LHM) are established treatments for idiopathic achalasia. Peroral endoscopic myotomy (POEM) is a less invasive therapy with promising early study results. METHODS In a multicenter, randomized trial, we compared POEM with LHM plus Dor's fundoplication in patients with symptomatic achalasia. The primary end point was clinical success, defined as an Eckardt symptom score of 3 or less (range, 0 to 12, with higher scores indicating more severe symptoms of achalasia) without the use of additional treatments, at the 2-year follow-up; a noninferiority margin of -12.5 percentage points was used in the primary analysis. Secondary end points included adverse events, esophageal function, Gastrointestinal Quality of Life Index score (range, 0 to 144, with higher scores indicating better function), and gastroesophageal reflux. RESULTS A total of 221 patients were randomly assigned to undergo either POEM (112 patients) or LHM plus Dor's fundoplication (109 patients). Clinical success at the 2-year follow-up was observed in 83.0% of patients in the POEM group and 81.7% of patients in the LHM group (difference, 1.4 percentage points; 95% confidence interval [CI], -8.7 to 11.4; P = 0.007 for noninferiority). Serious adverse events occurred in 2.7% of patients in the POEM group and 7.3% of patients in the LHM group. Improvement in esophageal function from baseline to 24 months, as assessed by measurement of the integrated relaxation pressure of the lower esophageal sphincter, did not differ significantly between the treatment groups (difference, -0.75 mm Hg; 95% CI, -2.26 to 0.76), nor did improvement in the score on the Gastrointestinal Quality of Life Index (difference, 0.14 points; 95% CI, -4.01 to 4.28). At 3 months, 57% of patients in the POEM group and 20% of patients in the LHM group had reflux esophagitis, as assessed by endoscopy; at 24 months, the corresponding percentages were 44% and 29%. CONCLUSIONS In this randomized trial, POEM was noninferior to LHM plus Dor's fundoplication in controlling symptoms of achalasia at 2 years. Gastroesophageal reflux was more common among patients who underwent POEM than among those who underwent LHM.
Návaznosti
90090, velká výzkumná infrastruktura |
|